In this paper, the relationship between the medical effectiveness and cost-effectiveness of endoscopic treatments such as injection hemostasis with pure ethanol and endoscopic mucosal resection (EMR) was evaluated by analyzing the average length of hospital stay and the medical cost. The clinical use of injection hemostasis and intravenous H2 blocker antagonists for bleeding peptic ulcers has remarkably decreased the number of operative cases, the average length of hospital stay and overall medical cost. The cases of EMR for superficial esophageal cancer and early gastric cancer at the endoscopy center of Tokai University Hospital from January 1991 to December 1995 were analyzed. The number of cases treated by EMR increased about 10 times during the five year period, while surgical cases did not increased in the same period. Recently, because EMR is a minimally invasive procedure, inoperative cases with severely complicated diseases can be treated by EMR. In cases treated for superficial esophageal cancer, the average length of hospital stay is about 75% shorter compared with surgical cases. In addition, the treatment cost of EMR in much lower than the surgical operation. In cases of EMR for patients with severely complicated diseases and/or patients over 65 years of age, the average length of hospital stay after EMR is longer. Inevitably, the average length of hospital stay in the EMR cases for early gastric cancer retreated is longer than that of superficial esophageal cancer. Considering the economical decline and aging society in our country, the standardization of JCAHO (Joint Commission on Accreditation of Healthcare Organization) and DRG (Diagnosis Related Group)/PPS (Prospective Payment System) in the USA would be necessitated. The clinical standardization of gastrointestinal endoscopy by JGES (Japan Gastrointestinal Endos-copy Society) would be useful and socially acceptable in the renewal of the national health insurance system in Japan.
View full abstract